Accéder au contenu
Merck

Fbw7 dimerization determines the specificity and robustness of substrate degradation.

Genes & development (2013-12-04)
Markus Welcker, Elizabeth A Larimore, Jherek Swanger, Maria T Bengoechea-Alonso, Jonathan E Grim, Johan Ericsson, Ning Zheng, Bruce E Clurman
RÉSUMÉ

The Fbw7 tumor suppressor targets a broad network of proteins for ubiquitylation. Here we show critical functions for Fbw7 dimerization in regulating the specificity and robustness of degradation. Dimerization enables Fbw7 to target substrates through concerted binding to two suboptimal and independent recognition sites. Accordingly, an endogenous dimerization-deficient Fbw7 mutation stabilizes suboptimal substrates. Dimerization increases Fbw7's robustness by preserving its function in the setting of mutations that disable Fbw7 monomers, thereby buffering against pathogenic mutations. Finally, dimerization regulates Fbw7 stability, and this likely involves Fbw7 trans-autoubiquitylation. Our study reveals novel functions of Fbw7 dimerization and an unanticipated complexity in substrate degradation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Hydroxyde de tétraméthylammonium pentahydrate, ≥97%
Sigma-Aldrich
Tetramethylammonium chloride solution, for molecular biology
Sigma-Aldrich
Hydroxyde de tétraméthylammonium pentahydrate, ≥95.0% (T)
Sigma-Aldrich
Chlorure de tétraméthylammonium, reagent grade, ≥98%
Sigma-Aldrich
Tetramethylammonium iodide, 99%
Sigma-Aldrich
Chlorure de tétraméthylammonium, BioUltra, for molecular biology, ≥99.0% (AT)
Supelco
Chlorure de tétraméthylammonium, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)
Sigma-Aldrich
Hydroquinidine, 95%
Supelco
Sulfate de tétraméthylammonium, suitable for ion pair chromatography, LiChropur, ≥99.0% (T)